LEADER 03502nam  22006615  450 
001 9910574855303321
005 20251202134013.0
010   $a981-16-9186-X
024 7 $a10.1007/978-981-16-9186-7
035   $a(MiAaPQ)EBC7013174
035   $a(Au-PeEL)EBL7013174
035   $a(CKB)23524782600041
035   $aEBL7013174
035   $a(AU-PeEL)EBL7013174
035   $a(BIP)84483425
035   $a(BIP)82452453
035   $a(DE-He213)978-981-16-9186-7
035   $a(EXLCZ)9923524782600041
100   $a20220607d2022      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aRole of MicroRNAs in Cancers /$fedited by DKV Prasad, Pinninti Santosh Sushma
205   $a1st ed. 2022.
210  1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2022.
215   $a1 online resource (183 pages)
300   $aDescription based upon print version of record.
311 08$aPrint version: Prasad, D. K. V. Role of MicroRNAs in Cancers Singapore : Springer,c2022 9789811691850 
327   $aChapter 1. Introduction to microRNAs and cancers -- Chapter 2. microRNAs and cancer signaling pathways -- Chapter 3. Role of microRNAs in cell growth proliferation and tumorigenesis -- Chapter 4. Impact of microRNAs in cell adhesion and tumor angiogenesis -- Chapter 5. Modulation of oxidative stress by microRNAs in cancers -- Chapter 6. microRNAs targeting tumor microenvironment and immune modulation -- Chapter 7. Circulating miRNA in prognosis, diagnosis and their role in controlling the fate of cancer stem cells -- Chapter 8. The role of miRNAs in the regulation of drug resistance among different cancers -- Chapter 9. The mechanisms of miRNA deregulation in cancer outbreak -- Chapter 10. Bioinformatic profiling of miRNAs in Cancers.
330   $aThis book discusses the potential roles of miRNA as a crucial regulator in cancer biology. It examines the regulation of drug resistance by miRNAs in cancers and the mechanism of their deregulated expression. The book discusses the role and molecular mechanism of miRNA in regulating cellular proliferation and cell cycle. It analyses circulating miRNAs as biomarkers for cancer diagnosis and prognosis. It also analyzes the role of miRNA as a modulator of the development and function of tumor-associated immune cells. It explores the cross-talk between miRNA and reactive oxygen species (ROS) in pathogenesis, cancer therapeutic tolerance, and resistance. It provides insights into the role of miRNA in cancer angiogenesis, metastasis and describes strategies and associated challenges of miRNA-based therapies.
606   $aCancer$xTreatment
606   $aRNA interference
606   $aImmunology
606   $aBiochemical markers
606   $aCancer Therapy
606   $aRNA Interference
606   $aImmunology
606   $aBiomarkers
615  0$aCancer$xTreatment.
615  0$aRNA interference.
615  0$aImmunology.
615  0$aBiochemical markers.
615 14$aCancer Therapy.
615 24$aRNA Interference.
615 24$aImmunology.
615 24$aBiomarkers.
676   $a616.994042
700   $aPrasad$b D. K. V.$01241230
702   $aSantosh Sushma$b Pinninti
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910574855303321
996   $aRole of MicroRNAs in Cancers$92879347
997   $aUNINA